There are a number of reasons why a party facing an adverse decision in federal court might wish to seek reconsideration prior to appealing. But a word of caution is in order: as a recent decision from the United States Court...more
Federal Circuit Interprets Statutory Requirements for Biosimilar Regulatory Pathway - Amgen Inc., v. Sandoz Inc., (Fed. Cir. July 21, 2015): In a case of first impression, the U.S. Court of Appeals for the Federal...more